Uptake was low in brain ( z 0.04% dose/g) and highest ( z l-2% dose/g) in the spleen and lungs. The present findings indicate that the use of [ "C]CP 96,345 in PET might be more applicable to the study of substance P receptors in peripheral tissues involved with inflammatory disease and arthritis.
Introduction
The compound CP 96,345 has recently been reported to be the first potent nonpeptide antagonist of substance P (Lowe et al., , 1992 McLean et al., 1991; Snider et al., 1991) . CP 96,345 binds stereoselectively and with high affinity (& = 0.2 nM) to the substance P (NK-1) receptor (Lowe et al., 1992; Snider et al., 1991) . Radiolabeled CP 96, 345 has the potential for in vitro and in vivo localization of substance P receptor sites. Successful mapping of substance P receptor sites may yield useful diagnostic information in the study of arthritis, inflammatory diseases and carcinoid tumor (Payan, 1989) . A preliminary account of the characterization of substance P receptor sites in guinea pig brain using [)H]CP 96,345 has been published (McLean, 1991) . The present work describes the synthesis of carbon-l 1 analogue CP 96,345 suitable for Positron Emission Tomography applications and its in vivo tissue distribution in guinea pigs.
Radiosynthesis

Experimental
["C]CP 96,345, 3 (Fig. l) , was prepared by reaction of (2S,3S)-cis-2-(diphenylmethyl)-N-[(2-hydroxy-*Author for correspondence. phenyl)methyl]-l-azabicyclo[2.2.2]-octan-3-amine, 2, with ["Clmethyl iodide. The desmethyl precursor 2 was prepared from the previously reported optically active compound 1 (Lowe et al., 1992) by imine formation with salicylaldehyde ( Fig. 1 ) followed by reduction with boranejmethyl sulfide. Compound 2 (l-2 mg) was dissolved in 8-9 p L of 1 M tetrabutylammonium hydroxide in methanol (Aldrich Chemical Co.) in a septum-capped vial. The methanolic solution was evaporated under a gentle stream of nitrogen for l-2 h and the residue of phenolate salt was dissolved in 150-200 p L of dimethyl formamide. The [ "Clmethyl iodide was trapped in the solution at -40°C and the reaction mixture was subsequently heated at 85-90°C for 5 min. ["C]CP 96,345 was purified by reverse phase HPLC using a Waters Bondapak CN column (3.9 x 300 mm) eluted with ethanol/O.1 M ammonium acetate (1: 4). [ "C]CP 96,345 eluted at 19-20min at a flow rate of 2.3 mL/min. Radiochemical yields of 30-50% (decay corrected) were obtained in a total synthesis time of 4560min to 1 h from end-of-beam. Analytical HPLC of the HPLC purified 3 showed a high radiochemical purity (< 95%) and a specific activity > 1000 Ci/mmol (end-of-synthesis).
An authentic sample of CP 96,345 provided by Pfizer, was used as a reference standard. Radiochromatographic analysis was performed with a 4.6 x 250 mm Phenomenex Ultremex Cl8 IP using acetonitrile/O.l M ammonium acetate (95: 5, 3.0 mL/min) as solvent. 
Animal studies
[ "C]CP 96,345 was formulated for animal injection by a nine-fold dilution of the HPLC purified product with physiologic saline. Guinea pigs were anesthesized with ether, administered 50-100 PCi via femoral vein injection of the above formulation and sacrificed at 5 and 30 min. Biodistribution data for two guinea pigs per each time point in the brain and peripheral tissues are given in Tables 1 and 2 .
Results and Discussion
The chiral phenolic precursor 2 was prepared from the intermediate quinuclidine amine 1 (Lowe et al., : 1992) ( (McLean et al., 1991) . Furthermore, the regional binding of substance P to substance P(NK-1) receptors have been studied in the guinea pig brain (Dam , 1986) . Biodistribution data for [ "C]CP 96,345 in various brain tissues and peripheral tissues 5 and 30 min post-injection (n = 2 guinea pigs) are summarized in Tables 1 and 2 . Table 1 shows that the overall brain uptake of [ "C]CP 96,345 was minimal, ~0.1% of the injected dose at 30 min. The distribution of activity was nearly uniform (~0.04% dose/g) and nonselective in various regions of the brain, including the striatum, cerebellum, cortex, hypothalmus, hippocampus and olfactory bulb. The calculated variances for brain regions (Table 1) were very small with a maximum value of 0.0002 for the olfactory bulb. Brain activity levels were slightly lower than blood activity and ~3 times lower than heart activity. Table 2 shows that highest peripheral accumulation of activity occurred in the spleen and lungs. For tissues in Table 1 , the calculated variances were higher, ranging from 0.00006 to 0.670. Regional selective binding of both [ 3H]substance P (Dam and Quirion, 1986) Table 1 were very small, additional in vivo studies with larger groups of animals were not conducted.
Based on the present preliminary evaluation of [ "C]CP 96,345, we conclude that CP 96,345 is unsuitable as an in uivo marker of substance P receptors in the brain. HPLC data and log P measurements (log P = 4.5) indicate that the free base form of CP 96,345, with its two highly basic nitrogens, may exist mostly in cationic form, either a monocation or possibly even a dication, thus precluding its passage through the blood-brain barrier. Alternative experiments for the low brain uptake, such as extensive binding to blood proteins, cannot be ruled out. PET studies with ["C]CP 96,345 might be more appropriately applied to the detection of substance P receptors in tissue regions of interest involved with inflammatory disease and arthritis (Payan, 1989) . Studies to determine the specific binding of ["C]CP 96,345 to various peripheral tissues and its applications in animal models of such diseases are underway.
